BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 28848075)

  • 1. MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density.
    Papin C; Ibrahim A; Sabir JSM; Le Gras S; Stoll I; Albiheyri RS; Zari AT; Bahieldin A; Bellacosa A; Bronner C; Hamiche A
    J Exp Clin Cancer Res; 2023 Nov; 42(1):301. PubMed ID: 37957685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.
    van Bemmel D; Lenz P; Liao LM; Baris D; Sternberg LR; Warner A; Johnson A; Jones M; Kida M; Schwenn M; Schned AR; Silverman DT; Rothman N; Moore LE
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1143-8. PubMed ID: 22539607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells.
    Bader SA; Walker M; Harrison DJ
    Br J Cancer; 2007 Feb; 96(4):660-6. PubMed ID: 17285135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma.
    Valiulyte I; Steponaitis G; Skiriute D; Tamasauskas A; Vaitkiene P
    BMC Med Genet; 2017 Jul; 18(1):72. PubMed ID: 28709401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of
    Li J; Ye D; Wang L; Peng Y; Li Q; Deng H; Zhou C
    Onco Targets Ther; 2018; 11():651-663. PubMed ID: 29440913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine-5 methylation.
    Shao D; Liu C; Wang Y; Lin J; Cheng X; Han P; Li Z; Jian D; Nie J; Jiang M; Wei Y; Xing J; Guo Z; Wang W; Yi X; Tang H
    FASEB J; 2023 Dec; 37(12):e23284. PubMed ID: 37905981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper tract urothelial carcinoma: a different disease entity in terms of management.
    Leow JJ; Chong KT; Chang SL; Bellmunt J
    ESMO Open; 2016; 1(6):e000126. PubMed ID: 28848663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
    Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
    Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
    Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
    Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
    Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
    Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin Remodeling and Epigenetic Regulation in Plant DNA Damage Repair.
    Kim JH
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions.
    Jasek K; Kubatka P; Samec M; Liskova A; Smejkal K; Vybohova D; Bugos O; Biskupska-Bodova K; Bielik T; Zubor P; Danko J; Adamkov M; Kwon TK; Büsselberg D
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31323834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.
    Ma Y; Chen Y; Petersen I
    Pathol Res Pract; 2017 Apr; 213(4):333-338. PubMed ID: 28214209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
    Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of DNA repair gene methylation in blood of chronic fluorosis patients and rats.
    Wu CX; Wang YH; Li Y; Guan ZZ; Qi XL
    J Trace Elem Med Biol; 2018 Dec; 50():223-228. PubMed ID: 30262283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 17. Identifying DNA methylation biomarkers of cancer drug response.
    Maier S; Dahlstroem C; Haefliger C; Plum A; Piepenbrock C
    Am J Pharmacogenomics; 2005; 5(4):223-32. PubMed ID: 16078859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer.
    Wojtczyk-Miaskowska A; Presler M; Michajlowski J; Matuszewski M; Schlichtholz B
    Cell Physiol Biochem; 2017; 42(6):2404-2417. PubMed ID: 28848075
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.